Literature DB >> 20374365

Fc gamma receptor biology and systemic lupus erythematosus.

Vojislav Jovanovic1, Xilei Dai, Yan Ting Lim, David M Kemeny, Paul A MacAry.   

Abstract

The maintenance of immune homeostasis and the regulation of pro-inflammatory responses that underlie autoimmune pathology require a coordinated interplay between cytokines, cellular receptors and downstream signaling pathways. The family of fragment crystallizable receptors for immunoglobulin G (IgG) (Fc gammaR) represents a good example of how controlling the simultaneous triggering of activatory and/or inhibitory receptors results in a balanced immune response. Fc gammaRs play a crucial role in linking the antibody-mediated recognition of pathogens, allergens or auto-antigens to the cellular arm of the immune response. In this review, we detail how dysfunction in Fc gammaR pathways is linked to the development of the autoimmune disease, systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20374365     DOI: 10.1111/j.1756-185X.2009.01426.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

Review 1.  Mechanisms of human autoimmunity.

Authors:  Michael D Rosenblum; Kelly A Remedios; Abul K Abbas
Journal:  J Clin Invest       Date:  2015-06-01       Impact factor: 14.808

Review 2.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

3.  Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model.

Authors:  Wanjing Ding; Hiroyuki Shimada; Lin Li; Rahul Mittal; Xiaokun Zhang; Koichi Shudo; Qiaojun He; Nemani V Prasadarao; Lingtao Wu
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

4.  Fc Gamma Receptors as Regulators of Bone Destruction in Inflammatory Arthritis.

Authors:  Yuyue Zuo; Guo-Min Deng
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.